Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double-blind, randomized, placebo-controlled, dose-ranging trial - Croop, R; Madonia, J; Stock, D A; Thiry, A; Forshaw, M; Murphy, A (Headache: The Journal of Head and Face Pain, 2022)